CLDX

Celldex Therapeutics (CLDX)

Celldex Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CLDX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	21:01	GlobeNewswire Inc.	Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/07	05:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/07	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/05/07	05:01	GlobeNewswire Inc.	Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/04/17	21:01	GlobeNewswire Inc.	Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/03/08	21:00	GlobeNewswire Inc.	Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/03/06	00:30	GlobeNewswire Inc.	Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/03/06	00:10	GlobeNewswire Inc.	Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/03/02	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/03/02	06:09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/03/01	11:14	GlobeNewswire Inc.	Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/29	06:10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/29	06:01	GlobeNewswire Inc.	Celldex Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/26	22:18	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/26	21:05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/26	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/26	21:01	GlobeNewswire Inc.	Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/25	04:05	GlobeNewswire Inc.	Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/16	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/15	06:17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/15	02:52	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/15	01:48	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/14	21:38	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/13	23:41	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/09	00:11	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/07	06:01	GlobeNewswire Inc.	Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/02/05	22:01	GlobeNewswire Inc.	Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/01/05	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLDX	Celldex Therapeutics Inc
2023/11/28	06:15	GlobeNewswire Inc.	Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference	NASDAQ:CLDX	Celldex Therapeutics Inc
2023/11/21	06:15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CLDX	Celldex Therapeutics Inc